Department of Surgery, Western University, Ontario, Canada; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Surgery and Transplantation, University Hospital Zurich, Switzerland.
HPB (Oxford). 2021 Jan;23(1):46-55. doi: 10.1016/j.hpb.2020.04.009. Epub 2020 May 23.
Various, often conflicting, estimates for post-operative morbidity and mortality following ALPPS have been reported in the literature, suggesting that considerable center-level variation exists. Some of this variation may be related to center volume and experience.
Using data from seventeen centers who were early adopters of the ALPPS technique, we estimated the variation, by center, in standardized 90-day mortality and comprehensive complication index (CCI) for patients treated between 2012 and 2018.
We estimated that center-specific 90-day mortality following treatment with ALPPS varied from 4.2% (95% CI: 0.8, 9.9) to 29.1% (95% CI: 13.9, 50.9), and that center-specific CCI following treatment with ALPPS varied from 17.0 (95% CI: 7.5, 26.5) to 49.8 (95% CI: 38.1, 61.8). Declines in estimated 90-day mortality and CCI were observed over time, and almost all individual centers followed this trend. Patients treated at centers with a higher number of ALPPS cases performed over the prior year had a lower risk of post-operative mortality.
Despite considerable center-level variation in ALPPS outcomes, perioperative outcomes following ALPPS have improved over time and treatment at higher volume centers results in a lower risk of 90-day mortality. Morbidity and mortality remain concerningly high at some centers.
文献中报道了各种(常常相互冲突的)ALPPS 术后发病率和死亡率的估计值,这表明存在相当大的中心间差异。这种差异的部分原因可能与中心的数量和经验有关。
我们使用了 17 个早期采用 ALPPS 技术的中心的数据,估计了 2012 年至 2018 年期间接受治疗的患者在中心层面上标准化 90 天死亡率和综合并发症指数(CCI)的差异。
我们估计,采用 ALPPS 治疗后,中心特异性 90 天死亡率从 4.2%(95%CI:0.8,9.9)到 29.1%(95%CI:13.9,50.9)不等,采用 ALPPS 治疗后中心特异性 CCI 从 17.0(95%CI:7.5,26.5)到 49.8(95%CI:38.1,61.8)不等。随着时间的推移,估计的 90 天死亡率和 CCI 呈下降趋势,几乎所有的中心都遵循这一趋势。在过去一年中接受 ALPPS 例数较多的中心治疗的患者,术后死亡率较低。
尽管 ALPPS 结果存在相当大的中心间差异,但 ALPPS 术后的围手术期结果随着时间的推移有所改善,在高容量中心治疗可降低 90 天死亡率的风险。在一些中心,发病率和死亡率仍然令人担忧地高。